| Name | Title | Contact Details |
|---|
DiagnoCure (TSX: CUR; OTCQX: DGCRF) is a life sciences corporation that develops and commercializes high-value cancer diagnostic tests that increase clinician and patient confidence in making critical treatment decisions. In 2008, the Corporation launched a colorectal cancer staging test through its U.S. CLIA laboratory. PrevistageTM GCC is currently available for licensing. The Corporation has granted a worldwide exclusive license on the diagnostic applications of its proprietary molecular biomarker PCA3 to Gen-Probe, now a wholly-owned subsidiary of Hologic Inc. Hologic Gen-Probe's PROGENSA® PCA3 prostate cancer test is commercialized in Europe under CE mark and is approved for commercialization in Canada and the United States.
First MCO is unique in the worker`s compensation industry in that it develops networks of specialists where the employers have the ability to direct care to them. With a rich 36-year company history, First MCO has grown into national experts in driving care for private and public sectors. The company works with insurance companies, self-insurers, third party administrators and insurance funds to provide comprehensive medical management and cost containment services for workers` compensation in New Jersey, Nevada, Missouri, Pennsylvania, Virginia, and Connecticut. The skilled medical team and professional staff at First MCO pride themselves on individualized customer service and convenient managed care solutions to get people back to work.
Increasing Accessibility to Clinical Trials and Personalized Cancer Treatment Options. Every cancer patient is different and deserves treatment of the highest quality that is personalized, affordable, and easily accessible. Massive Bio translates the world-class oncology knowledge of the large cancer centers experts, facilitates a virtual tumor board collaboratively with the treating oncologist, and advises the patient and treating oncologist to operationalize these expert recommendations at the point of care thereby, eliminating additional time, travel, and cost. 85% of US cancer patients receive treatments in community practices where treating oncologists are overwhelmed with the influx of new tests and treatments while trying to manage their busy practices. We believe all cancer patients deserve equal access to the latest in cancer research and treatment.
Nivano Physicians is an Independent Physician Association (IPA) that operates within Sacramento and surrounding counties. They are committed to advocating for the Medi-Cal community and ensuring that managed healthcare is manageable.
American Habilitation Svc is a Austin, TX-based company in the Healthcare, Pharmaceuticals, and Biotech sector.